CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Advanz Pharma Corp Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Advanz Pharma Corp Ltd
Capital House, 85 King William Street
Phone: +44 2085889100p:+44 2085889100 London, EC4N 7BL  United Kingdom Ticker: 80CD80CD
This company was Merged or Acquired on 6/1/2021.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
ADVANZ PHARMA Corp. Limited is a United Kingdom-based pharmaceutical company. It is an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, and sales in more than 90 countries. The Company is focused on investing in product portfolio to optimize healthcare treatment. Its therapy areas include endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders and intensive care medicines. The Company optimizes healthcare treatment through product acquisitions, in-licensing opportunities, product development and alliances worldwide. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products and operates facilities in various locations, including Sydney, Australia; Mumbai, India; Dublin, Ireland; St. Helier, Jersey; Helsingborg, Sweden, and Chicago, United States.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes--Yes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202112/31/2020YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Elmar J.Schnee 60 1/1/2020 1/1/2020
Chief Executive Officer, Director GraemeDuncan 45 5/2/2018 5/2/2018
Chief Financial Officer, Interim Director AdeelAhmad 45 1/1/2020 6/1/2018
7 additional Officers and Directors records available in full report.

Business Names
Business Name
3ZJ
80CD
Abcur AB
44 additional Business Names available in full report.

General Information
Number of Employees: 429 (As of 12/31/2019)
Outstanding Shares: 48,913,490 (As of 3/31/2021)
Stock Exchange: OTC
Fax Number: +44 2085889200


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 5, 2024